BridgeBio Pharma Statistics

Total Valuation

BIT:1BBIO has a market cap or net worth of EUR 10.79 billion. The enterprise value is 11.90 billion.

Market Cap	10.79B
Enterprise Value	11.90B

Important Dates

The last earnings date was Tuesday, February 24, 2026.

Earnings Date	Feb 24, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	193.86M
Shares Outstanding	n/a
Shares Change (YoY)	+2.93%
Shares Change (QoQ)	+0.89%
Owned by Insiders (%)	4.12%
Owned by Institutions (%)	83.83%
Float	159.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	25.23
PB Ratio	-6.10
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-19.27
EV / Sales	27.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-31.25

Financial Position

The company has a current ratio of 2.77

Current Ratio	2.77
Quick Ratio	2.52
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-4.17
Interest Coverage	-2.82

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-33.83%
Return on Invested Capital (ROIC)	-1,066.15%
Return on Capital Employed (ROCE)	-77.47%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	510,894
Profits Per Employee	-737,663
Employee Count	839
Asset Turnover	0.54
Inventory Turnover	n/a

Taxes

In the past 12 months, BIT:1BBIO has paid 370,490 in taxes.

Income Tax	370,490
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	63.22
200-Day Moving Average	49.43
Relative Strength Index (RSI)	36.02
Average Volume (20 Days)	28

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.62

Income Statement

In the last 12 months, BIT:1BBIO had revenue of EUR 427.62 million and -617.42 million in losses. Loss per share was -3.22.

Revenue	427.62M
Gross Profit	409.76M
Operating Income	-427.61M
Pretax Income	-623.87M
Net Income	-617.42M
EBITDA	-422.98M
EBIT	-427.61M
Loss Per Share	-3.22

Full Income Statement

Balance Sheet

The company has 500.36 million in cash and 1.59 billion in debt, with a net cash position of -1.09 billion.

Cash & Cash Equivalents	500.36M
Total Debt	1.59B
Net Cash	-1.09B
Net Cash Per Share	n/a
Equity (Book Value)	-1.77B
Book Value Per Share	-9.12
Working Capital	434.18M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -379.78 million and capital expenditures -934,315, giving a free cash flow of -380.72 million.

Operating Cash Flow	-379.78M
Capital Expenditures	-934,315
Free Cash Flow	-380.72M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 95.82%, with operating and profit margins of -100.00% and -144.39%.

Gross Margin	95.82%
Operating Margin	-100.00%
Pretax Margin	-145.89%
Profit Margin	-144.39%
EBITDA Margin	-98.92%
EBIT Margin	-100.00%
FCF Margin	n/a

Dividends & Yields

BIT:1BBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.93%
Shareholder Yield	-2.93%
Earnings Yield	-5.72%
FCF Yield	-3.53%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BIT:1BBIO has an Altman Z-Score of -4.53 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.53
Piotroski F-Score	2